Bora Pharmaceuticals Completes Acquisition of First Aseptic Injectable Manufacturing Plant, Integrates Site Revenue

Yesterday (21st), Bora Pharmaceuticals announced the successful acquisition of an aseptic injectable manufacturing plant located in Camden, Maryland, from the U.S. company Emergent BioSolutions. The company has officially integrated the site's revenue and operations, enhancing the comprehensiveness of its CDMO (Contract Development and Manufacturing Organization) capabilities.